Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

US Patent 10155011 · Granted Dec 18, 2018

Estimated economic value: $18,812,000

Assignee

Inventors

View full patent text on Google Patents →